| 04/16/2026 3:15 PM | Aktis Oncology (2035832) Issuer Gormley Glenn (2127198) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 3:01 PM | Aktis Oncology (2035832) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/20/2026 4:44 PM | Aktis Oncology (2035832) Subject MPM BIOVENTURES 2018, L.P. (1729505) Filed by | Form SCHEDULE 13D | |
| 01/20/2026 1:01 PM | Aktis Oncology (2035832) Subject EcoR1 Capital, LLC (1587114) Filed by | Form SCHEDULE 13D | |
| 01/15/2026 5:01 AM | Aktis Oncology (2035832) Issuer ELI LILLY & Co (59478) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/15/2026 5:02 AM | Aktis Oncology (2035832) Subject ELI LILLY & Co (59478) Filed by | Form SCHEDULE 13D | |
| 01/14/2026 5:17 PM | Aktis Oncology (2035832) Issuer GADICKE ANSBERT (1134655) Reporting MPM ASSET MANAGEMENT LLC (1263048) Reporting Oncology Impact Private Investment Fund 2, L.P. (2104306) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/14/2026 5:19 PM | Aktis Oncology (2035832) Issuer EVNIN LUKE (1134657) Reporting MPM ASSET MANAGEMENT INVESTORS BV2018 LLC (1734817) Reporting MPM BIOVENTURES 2018 (0) B MPM BioVentures 2018 GP LLC (1818701) Reporting MPM BioVentures 2018 LLC (1818702) Reporting MPM BIOVENTURES 2018, L.P. (1729505) Reporting MPM Oncology Innovations Fund GP LLC (1857903) Reporting MPM ONCOLOGY INNOVATIONS FUND LP (1719960) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/14/2026 5:20 PM | Aktis Oncology (2035832) Issuer Foley Todd (1473930) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/14/2026 3:58 PM | Aktis Oncology (2035832) Subject VV Manager II, LLC (1824569) Filed by | Form SCHEDULE 13D | |
| 01/12/2026 7:28 PM | Aktis Oncology (2035832) Issuer EcoR1 Capital, LLC (1587114) Reporting NODELMAN OLEG (1454385) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for AKTS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aktis Oncology and its competitors with MarketBeat's FREE daily newsletter.
|
| 01/12/2026 4:10 PM | Aktis Oncology (2035832) Issuer Vida Ventures II, LLC (1776851) Reporting VIDA VENTURES II-A, LLC (1781930) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 3:49 PM | Aktis Oncology (2035832) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 01/12/2026 4:00 PM | Aktis Oncology (2035832) Issuer Segal Lloyd Mitchell (1477123) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 4:00 PM | Aktis Oncology (2035832) Issuer Kim Helen Susan (1422772) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 3:03 PM | Aktis Oncology (2035832) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/09/2026 4:01 PM | Aktis Oncology (2035832) Filer | Form 424B4 | |
| 01/08/2026 11:15 PM | Aktis Oncology (2035832) Filer | Form EFFECT | |
| 01/08/2026 8:19 PM | Aktis Oncology (2035832) Issuer Kuvalanka Kyle D. (1638904) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/08/2026 8:00 PM | Aktis Oncology (2035832) Issuer Sherman Michael A. (1509463) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/08/2026 8:02 PM | Aktis Oncology (2035832) Issuer Czibere Akos (2049427) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/08/2026 8:02 PM | Aktis Oncology (2035832) Issuer Feldman Paul L (2050705) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/08/2026 8:03 PM | Aktis Oncology (2035832) Issuer Foley Todd (1473930) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/08/2026 8:03 PM | Aktis Oncology (2035832) Issuer Ron-Bigger Shulamit (2049407) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/08/2026 8:04 PM | Aktis Oncology (2035832) Issuer EVNIN LUKE (1134657) Reporting MPM ASSET MANAGEMENT INVESTORS BV2018 LLC (1734817) Reporting MPM BIOVENTURES 2018 (0) B MPM BioVentures 2018 GP LLC (1818701) Reporting MPM BioVentures 2018 LLC (1818702) Reporting MPM BIOVENTURES 2018, L.P. (1729505) Reporting MPM Oncology Innovations Fund GP LLC (1857903) Reporting MPM ONCOLOGY INNOVATIONS FUND LP (1719960) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/08/2026 8:05 PM | Aktis Oncology (2035832) Issuer RODEN MATTHEW (1828130) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/08/2026 8:05 PM | Aktis Oncology (2035832) Issuer Segal Lloyd Mitchell (1477123) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/08/2026 8:05 PM | Aktis Oncology (2035832) Issuer GADICKE ANSBERT (1134655) Reporting MPM ASSET MANAGEMENT LLC (1263048) Reporting Oncology Impact Private Investment Fund 2, L.P. (2104306) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/08/2026 8:08 PM | Aktis Oncology (2035832) Issuer Herrmann Ken (2049757) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/08/2026 8:09 PM | Aktis Oncology (2035832) Issuer Kim Helen Susan (1422772) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/08/2026 7:49 PM | Aktis Oncology (2035832) Issuer EcoR1 Capital, LLC (1587114) Reporting NODELMAN OLEG (1454385) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/08/2026 7:57 PM | Aktis Oncology (2035832) Issuer Thistle Mary (1317917) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/08/2026 7:41 PM | Aktis Oncology (2035832) Issuer Vida Ventures II, LLC (1776851) Reporting VIDA VENTURES II-A, LLC (1781930) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/08/2026 11:44 AM | Aktis Oncology (2035832) Filer | Form CERT | |
| 01/07/2026 6:19 AM | Aktis Oncology (2035832) Filer | Form S-1/A | |
| 01/05/2026 5:31 AM | Aktis Oncology (2035832) Filer | Form S-1/A | |
| 12/19/2025 3:02 PM | Aktis Oncology (2035832) Filer | Form S-1 Registration statement under Securities Act of 1933 | |